Ubenimex is a potent enzyme inhibitor that functions by targeting aminopeptidase B, aminopeptidase N, and leukotriene A4 hydrolase. Frequently studied for its therapeutic potential in the treatment of… Read more











Ubenimex is a potent enzyme inhibitor that functions by targeting aminopeptidase B, aminopeptidase N, and leukotriene A4 hydrolase. Frequently studied for its therapeutic potential in the treatment of acute myeloid leukemia, this compound is a subject of ongoing pharmaceutical research. This category provides an essential selection of Ubenimex reference standards, including pharmacopeial and non-pharmacopeial impurities, potential metabolites, and stable isotope labelled compounds. These materials serve as critical tools for analytical laboratories performing comprehensive impurity profiling, method development, and routine quality control. By utilizing these precise standards, researchers can ensure the accuracy and reliability of analytical data required for the characterization and stability testing of drug formulations throughout the pharmaceutical development lifecycle.